Trial to Describe the Safety and Immunogenicity of Fluzone®
NCT00524940
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Inactivated, Split-Virion Influenza Virus
Sponsor
Sanofi Pasteur, a Sanofi Company